AI assistant
Sending…
Sanofi — Director's Dealing 2019
Feb 15, 2019
1643_dirs_2019-02-15_ad2f317f-cdad-434c-94f3-a26e7e1bf7de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MyoKardia Inc (MYOK)
CIK: 0001552451
Period of Report: 2019-02-13
Reporting Person: Sanofi (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-13 | Common Stock (par value $0.0001) | S | 4168899 | $37.66 | Disposed | 0 | Indirect |
Footnotes
F1: On February 13, 2019, the reporting person sold 4,168,899 shares of MYOK at a price of $37.66 (the "Transaction"). As a result of the Transaction, the reporting person no longer owns shares of common stock of MYOK and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of MYOK.
More from Sanofi
Share Issue/Capital Change
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Report Publication Announcement
2026
May 27
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Capital/Financing Update
2026
May 18